Dyslipidaemia in non-insulin dependent diabetes: the need for a clinical intervention trial.
Welborn
T A
TA
Department of Endocrinology and Diabetes, Sir Charles Gairdner Hospital, Perth, WA, Australia.
D008076:Cholesterol, HDL / Q000097:blood; D002986:Clinical Trials as Topic; D002994:Clofibrate / Q000627:therapeutic use; D003327:Coronary Disease; D003924:Diabetes Mellitus, Type 2; D003925:Diabetic Angiopathies; D005260:Female; D015248:Gemfibrozil / Q000627:therapeutic use; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D015228:Hypertriglyceridemia; D008297:Male; D012307:Risk Factors
D008076:Cholesterol, HDL; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D002994:Clofibrate; D015248:Gemfibrozil